Inventor · disambiguated record
Francis Burrows
Also filed as: BURROWS FRANCIS · BURROWS FRANCIS J
13 granted patents·17 pending applications·2,429 citations·filing 1993–2025
96Inventor score
Files withUNIV TEXAS11KURA ONCOLOGY INC10CONFORMA THERAPEUTICS CORP4CASTRO JANUARIO E1FRITZ LAWRENCE1
Top patents by PatentIndex Score
30 records- 0199US6051230ACompositions for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1995·Granted Apr 18, 2000·406 cites·61 claims
- 0298US7125541B2Combined methods for tumor vasculature targeting and tumor treatment with radiotherapyUNIV TEXAS·Filed 2000·Granted Oct 24, 2006·86 cites·15 claims
- 0398US6261535B1Diagnostic methods for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1998·Granted Jul 17, 2001·209 cites·27 claims
- 0498US5863538ACompositions for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1995·Granted Jan 26, 1999·206 cites·23 claims
- 0598US5855866AMethods for treating the vasculature of solid tumorsUNIV TEXAS·Filed 1994·Granted Jan 5, 1999·469 cites·26 claims
- 0698US5776427AMethods for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1995·Granted Jul 7, 1998·379 cites·23 claims
- 0798US5660827AAntibodies that bind to endoglinUNIV TEXAS·Filed 1995·Granted Aug 26, 1997·299 cites·30 claims
- 0897US5965132AMethods and compositions for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1994·Granted Oct 12, 1999·171 cites·16 claims
- 0996US7112317B2Combined methods and compositions for tumor vasculature targeting and tumor treatmentUNIV TEXAS·Filed 2003·Granted Sep 26, 2006·47 cites·14 claims
- 1094US6004554AMethods for targeting the vasculature of solid tumorsUNIV TEXAS·Filed 1993·Granted Dec 21, 1999·129 cites·24 claims
- 1187US11672774B2Methods of treating squamous cell carcinomas with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2021·Granted Jun 13, 2023·1 cites·50 claims
- 1283US7465718B2Ansamycins having improved pharmacological and biological propertiesCONFORMA THERAPEUTICS CORP·Filed 2003·Granted Dec 16, 2008·27 cites·23 claims
- 1376US2024358703A1Methods for treating hematological malignancies and ewing's sarcomaKURA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 1469US2006210473A1VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatmentUNIV TEXAS·Filed 2006·Application pending·0 cites
- 1565US2023248683A1Methods of treating squamous cell carcinomas with farnesyltransferase inhibitorsKURA ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1664US2025255869A1Methods for treating hematological malignancies and ewing's sarcomaKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1762US11944627B2Methods for treating hematological malignancies and Ewing's sarcomaKURA ONCOLOGY INC·Filed 2018·Granted Apr 2, 2024·0 cites·20 claims
- 1861US2025152591A1Treatment of hematological malignancies with menin inhibitors and p-glycoprotein inhibitorsKURA ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1960US2025186445A1Treatment of cancer with menin inhibitors and immuno-oncology agentsUNIV HEALTH NETWORK·Filed 2023·Application pending·0 cites
- 2056US2024024301A1Methods of treating head and neck squamous cell carcinomaKURA ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 2155US2008051462A1Methods for treating genetically-defined proliferative disorders with HSP90 inhibitorsCONFORMA THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 2255US2007105874A1Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 InhibitorsCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 2354US2023095934A1Treatment of hematological malignancies with inhibitors of meninKURA ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2453US2008318338A1Assays and Implements for Determining and Modulating HSP90 Binding ActivityCONFORMA THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 2549US2023405008A1Treatment of hematological malignancies with inhibitors of meninKURA ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 2647US2006079493A1Methods for treating genetically- defined proliferative disorders with hsp90 inhibitorsFRITZ LAWRENCE·Filed 2002·Application pending·0 cites
- 2746US2006251574A1Cytotoxins and diagnostic imaging agents comprising hsp90 ligandsKAMAL ADEELA·Filed 2003·Application pending·0 cites
- 2844US2019192517A1Treatment of squamous cell carcinomas with inhibitors of erkKURA ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2943US2005074457A1Assays and implements for determining and modulating hsp90 binding activityFiled 2002·Application pending·0 cites
- 3036US2008280878A1Methods and Compositions for Treating Chronic Lymphocytic LeukemiaCASTRO JANUARIO E·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francis Burrows files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →